BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23743567)

  • 21. Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.
    Fan R; Hou WJ; Zhao YJ; Liu SL; Qiu XS; Wang EH; Wu GP
    Tumour Biol; 2016 Apr; 37(4):4655-63. PubMed ID: 26508030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
    Yang JH; Li XY; Wang X; Hou WJ; Qiu XS; Wang EH; Wu GP
    PLoS One; 2017; 12(8):e0182775. PubMed ID: 28813465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer.
    Liu CY; Hsu CC; Huang TT; Lee CH; Chen JL; Yang SH; Jiang JK; Chen WS; Lee KD; Teng HW
    Mol Oncol; 2018 Oct; 12(10):1706-1717. PubMed ID: 30063110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
    Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
    Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
    Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
    Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.
    Khanna A; Thoms JAI; Stringer BW; Chung SA; Ensbey KS; Jue TR; Jahan Z; Subramanian S; Anande G; Shen H; Unnikrishnan A; McDonald KL; Day BW; Pimanda JE
    Mol Cancer Res; 2020 May; 18(5):709-722. PubMed ID: 32079743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
    Chen PM; Wu TC; Cheng YW; Chen CY; Lee H
    Oncotarget; 2015 Jun; 6(16):14274-89. PubMed ID: 25881545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer.
    Chang YH; Yu CW; Lai LC; Tsao CH; Ho KT; Yang SC; Lee H; Cheng YW; Wu TC; Shiau MY
    Cancer; 2010 Oct; 116(20):4800-9. PubMed ID: 20578176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.
    Chen PM; Wu TC; Wang YC; Cheng YW; Sheu GT; Chen CY; Lee H
    Carcinogenesis; 2013 Nov; 34(11):2655-63. PubMed ID: 23784082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
    Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
    Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
    Guo T; Zhao S; Wang P; Xue X; Zhang Y; Yang M; Li N; Li Z; Xu L; Jiang L; Zhao L; Ma PC; Rosell R; Li J; Gu C
    Oncotarget; 2017 Jul; 8(29):48110-48125. PubMed ID: 28624808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway.
    Liu J; Wang M; Zhang X; Wang Q; Qi M; Hu J; Zhou Z; Zhang C; Zhang W; Zhao W; Wang X
    Tumour Biol; 2016 Feb; 37(2):2673-82. PubMed ID: 26404133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation.
    Cheng YW; Wu MF; Wang J; Yeh KT; Goan YG; Chiou HL; Chen CY; Lee H
    Cancer Res; 2007 Nov; 67(22):10686-93. PubMed ID: 18006810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4.
    He L; Deng H; Liu S; Chen J; Li B; Wang C; Wang X; Jiang Y; Ma N; Liu M; Xie D
    Cancer Commun (Lond); 2018 Aug; 38(1):53. PubMed ID: 30103827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
    Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
    Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer.
    Lei N; Peng B; Zhang JY
    Oncol Rep; 2014 Oct; 32(4):1689-94. PubMed ID: 25109354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis.
    Li Y; Wang M; Zhu X; Cao X; Wu Y; Fang F
    Dis Markers; 2019; 2019():2312439. PubMed ID: 31534561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.